What an Organ Donation Scandal Reveals — and What HHS Found Inside Network for Hope
A Kentucky organ procurement organization faces federal shutdown after investigators found 103 cases with concerning features. What the review reveals about oversight.
On August 6, 2026, the Department of Health and Human Services announced it was decertifying Network for Hope, a Kentucky-based organ procurement organization serving nearly 7 million people across four states. The action followed two separate federal investigations that identified what HHS called “persistent patient safety failures.”
The scrutiny traces to a 2021 incident in which the organization’s predecessor was accused of attempting to harvest organs from a man who was still alive.
What happened to TJ Hoover
In 2021, Anthony Thomas Hoover II overdosed and became unresponsive for two days. He was declared brain dead, and donation was authorized by his family. As surgeons prepared to harvest his organs, Hoover began showing signs of improvement.
According to reporting by Ars Technica, Hoover “began visibly crying, pulled his knees to his chest, and shook his head” as he was wheeled into surgery. Hospital staff refused to proceed with organ removal when Hoover appeared responsive in the operating room. The surgery was canceled. Hoover recovered but sustained lingering neurological injuries.
One worker at the facility claimed that a supervisor from Kentucky Organ Donor Affiliates — KODA, one of the organizations that would later merge to form Network for Hope — demanded they find another surgeon willing to proceed.
What the investigations found
The Hoover case drew federal attention. Two agencies investigated.
The Health Resources and Services Administration (HRSA) examined 351 cases in which donations were authorized but ultimately canceled. Investigators found “concerning features” in 103 of them — roughly 29 percent. Among those, 73 involved patients who displayed neurological signs that should have disqualified them for donation.
The Centers for Medicare and Medicaid Services (CMS), which certifies and oversees organ procurement organizations under 42 CFR Part 486, conducted a parallel review. Both investigations identified systemic issues around how death was determined and how donation proceeded.
The pattern investigators uncovered was not limited to the Hoover case. Organ harvesting had begun while some donors showed signs of life, including at least one patient described as “thrashing, crying, and shaking his head.”
How organ procurement organizations work
The United States has 55 federally designated organ procurement organizations, operated by approximately 53 distinct nonprofit entities. Each OPO holds an exclusive geographic territory, organized by county. Network for Hope serves Kentucky, parts of Indiana, Ohio, and West Virginia.
OPOs are barred from making clinical care decisions or declaring death. Those responsibilities belong to treating physicians. But OPOs are financially incentivized to identify and recover donors — creating a structural tension when the line between irreversible brain death and temporary unresponsiveness is unclear.
The investigations found that much of the concerning activity involved donations after circulatory death, a growing category in which patients die from stopped blood flow rather than confirmed brain death. Determining when to withdraw life support in these cases is medically complex. The incentives an OPO faces — more donors means more transplants, which means better performance metrics and federal funding — can blur the boundary between coordination and pressure.
What Network for Hope says
Network for Hope “strongly disagrees” with the HHS decision and plans to appeal. The organization claims compliance with federal policies and notes that it implemented a “pause” process — now codified as Kentucky law — allowing any party in the donation chain to halt the process if concerns arise. The organization helped draft the related regulations.
The pause process is a procedural safeguard. It does not address what investigators found: that in dozens of cases, patients showing neurological signs were still being processed for donation before someone intervened to stop it.
What happens next
If decertification stands, another organization will take over donation coordination across Network for Hope’s territory. The Association of Organ Procurement Organizations (AOPO) would likely manage the transition. For patients and families in Kentucky, Indiana, Ohio, and West Virginia, the practical effect is an administrative handoff — though trust in the system is harder to restore.
Hoover’s sister appeared at the HHS press briefing announcing the decertification proceedings. She and a former Network for Hope employee welcomed the decision.
Health and Human Services Secretary Robert F. Kennedy Jr. stated that the move addressed safety failures that persisted despite prior oversight. The Trump administration is executing the shutdown through CMS’s existing certification authority.
What the scandal reveals
The Hoover case is extraordinary. The investigation findings are more revealing.
A system in which 29 percent of canceled donations showed concerning features suggests that the problem was not one bad actor making one mistake under pressure. It suggests a culture in which the threshold for proceeding with donation was systematically lower than what the clinical evidence supported.
The structural incentive is clear. OPOs are measured by donor recovery rates. Federal funding and performance ratings depend on volume. When an organization’s financial survival depends on identifying donors, the line between aggressive coordination and coercive pressure becomes harder to maintain — especially in cases where brain death determination is medically uncertain.
The investigations also reveal what oversight looks like when it arrives late. KODA merged with LifeCenter Organ Donor Network in October 2024 to form Network for Hope. The merger combined two organizations into one entity serving nearly 7 million people. In 2025, the combined organization reported 299 donors who “saved 872 lives.” The federal investigations that led to decertification came after the merger, examining practices that predated it.
What remains uncertain is how widespread similar patterns are among the other 52 organizations. The HRSA and CMS reviews focused on Network for Hope because Hoover’s case drew public attention. Other OPOs operate under the same certification framework, the same performance metrics, and the same financial incentives. The investigations did not establish whether Kentucky was an outlier or a canary.
The pause process Network for Hope helped draft into Kentucky law is one response. It gives hospital staff a formal mechanism to halt donation when they have concerns. But a pause button addresses the symptom — a patient being processed who should not be — not the incentive structure that made processing them seem worth pursuing in the first place.
What the scandal makes visible is a tension built into how organ donation works in the United States. The system needs organizations that actively identify donors, because passive identification saves fewer lives. But active identification creates pressure to find donors where they may not safely exist. The 103 concerning cases out of 351 are not proof that most donations were improper. They are evidence that a substantial fraction of the donation pipeline required someone — a surgeon, a nurse, a family member, or in Hoover’s case, the patient himself — to intervene and say stop.